Brief: Cyclerion Co Received Deficiency Letter From Nasdaq

Korsana Biosciences

03/06/2022 21:08

June 3 (Reuters) - Cyclerion Therapeutics Inc  CYCN.O :
    * CYCLERION - ON JUNE 1, 2022 CO RECEIVED DEFICIENCY LETTER
FROM
NASDAQ
    * CYCLERION - BID PRICE FOR CO'S COMMON STOCK CLOSED BELOW
$1.00/SHARE MINIMUM BID PRICE REQUIREMENT FOR CONTINUED
INCLUSION ON NASDAQ

Further company coverage:  CYCN.O